vTv Therapeutics Inc. (VTVT)
vTv Therapeutics Inc. is a biopharmaceutical company in the clinical development stage, primarily focused on creating orally administered treatments, with a significant emphasis on diabetes. Its pipeline features lead candidates such as TTP399, an oral, small-molecule, liver-specific glucokinase activator targeting Type 1 diabetes. Another key investigational drug is HPP737, an oral phosphodiesterase type 4 (PDE4) inhibitor that does not cross the blood-brain barrier (non-CNS penetrant), designed to treat inflammatory conditions and psoriasis. Beyond these, vTv Therapeutics' broader clinical portfolio includes: TTP273, an oral small-molecule GLP-1 receptor agonist addressing postprandial glucose excursions in cystic fibrosis-related diabetes. HPP3033, which employs a non-electrophilic strategy to activate the Nrf2 pathway for chronic conditions linked to oxidative stress. Azeliragon, a RAGE antagonist being evaluated for inflammatory lung disorders, notably severe COVID-19, alongside pancreatic and breast cancers. HPP971, an Nrf2 activator aimed at renal diseases, developed in collaboration with pharmaceutical partners. Furthermore, vTv holds a licensing agreement with Reneo Pharmaceuticals, Inc. for the development and commercialization of its peroxisome proliferation-activated receptor delta agonist program, which features the compound HPP593. The company has also established various other licensing and research collaborations with entities such as Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd., Newsoara Biopharma Co., Ltd., JDRF International, and Novo Nordisk A/S. Established in 2015, vTv Therapeutics is headquartered in High Point, North Carolina, and operates as a subsidiary of MacAndrews & Forbes Incorporated.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
vTv Therapeutics Inc.
NASDAQ:VTVTHealthcare · Biotechnology
-4.59%$25.17
AH$25.17+0.00%vs close
Mkt Cap$99.52M
Float1.48M
O/S3.95M
Vol
$ Vol
RVOL
Inst Own40.7%
SI9.7%
Earnings
Dilution
Financials Summary
Revenue$0
Net Income-$26.97M
Total Assets$89.9M
Free Cash Flow-$25.25M
Debt & Equity
Equity 100%
Total Debt$0
Total Equity$64.44M
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
- 1:40Reverse splitNov 21, 202340 shares → 1
Balance Sheet Details
Assets$89.9M
Liabilities$25.46M
Accounts Receivable$0
Accounts Payable$1.13M
Inventory$0
PP&E (Net)$0
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 |
| Revenue | $0 | $1.02M | $0 | $2.02M | $4M | $6.41M | $2.76M | $12.43M | $291K | $634K | $519K | $1.55M | $976K |
| YoY Growth | - | - | - | -49.6% | -37.6% | 132.1% | -77.8% | 4172.9% | -54.1% | 22.2% | -66.5% | 58.7% | - |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 | $11.02M | $15.12M | $23.04M | $39.64M | $45.75M | $29.58M | $18.73M | $25.43M |
| Gross Profit | $0 | $1.02M | $0 | $2.02M | $4M | -$4.6M | -$12.36M | -$10.6M | -$39.35M | -$45.11M | -$29.07M | -$17.18M | -$24.46M |
| Gross Margin | - | 100.0% | - | 100.0% | 100.0% | -71.7% | -447.0% | -85.3% | -13522.0% | -7115.8% | -5600.2% | -1109.1% | -2505.9% |
| Research and Development | $17.86M | $11.55M | $13.6M | $12.36M | $13.32M | $11.02M | $15.12M | $23.04M | $39.64M | $45.75M | $29.58M | $18.73M | $25.43M |
| Selling, General, and Administrative | $14.95M | $13.65M | $11.91M | $12.2M | $12.34M | $7.25M | $8.54M | $9.22M | $11.33M | $9.91M | $9.08M | $11.72M | $11.38M |
| Other | $0 | $0 | $0 | $0 | $0 | -$11.02M | $0 | -$592K | -$190K | -$22K | -$2.96M | -$1.13M | -$534K |
| Total Operating Expenses | $32.81M | $25.2M | $25.5M | $24.56M | $25.67M | $7.25M | $23.66M | $32.26M | $50.97M | $55.65M | $38.66M | $30.45M | $36.81M |
| Operating Income (EBIT) | -$32.81M | -$24.18M | -$25.5M | -$22.54M | -$21.66M | -$11.85M | -$20.89M | -$19.82M | -$50.68M | -$55.02M | -$38.14M | -$28.9M | -$35.83M |
| Operating Margin | - | -2377.6% | - | -1116.9% | -540.9% | -184.8% | -755.9% | -159.4% | -17416.5% | -8678.2% | -7349.1% | -1865.5% | -3671.4% |
| Interest Expense | $6K | $0 | $13K | $15K | $12K | $692K | $1.83M | $3.29M | $3.09M | $398K | $1.74M | $6.01M | $11.82M |
| Interest Income | $1.87M | $1.56M | $472K | $352K | $1K | $12K | $53K | $61K | $117K | $87K | $0 | $0 | $0 |
| Other Income (Expense) | $1.73M | $1.57M | -$464K | -$2.33M | $4.05M | -$950K | -$946K | -$3.82M | -$3.17M | -$333K | -$2.96M | -$7.2M | -$12.37M |
| Income Before Tax (EBT) | -$31.08M | -$22.61M | -$25.97M | -$24.87M | -$17.62M | -$12.8M | -$21.84M | -$23.64M | -$53.85M | -$55.35M | -$41.11M | -$36.1M | -$48.2M |
| Income Tax Expense | $0 | $100K | $0 | $200K | $115K | $0 | $100K | $200K | $800K | $0 | $0 | $0 | $0 |
| Net Income | -$26.97M | -$18.46M | -$20.25M | -$19.16M | -$12.99M | -$8.5M | -$21.94M | -$7.91M | -$16.14M | -$16.35M | -$27.5M | -$36.1M | -$48.2M |
| Net Income Margin | - | -1815.3% | - | -949.7% | -324.3% | -132.5% | -793.7% | -63.6% | -5547.8% | -2579.2% | -5298.3% | -2330.6% | -4938.8% |
| Supplementary Data | |||||||||||||
| EPS | -3.20 | -3.20 | -9.71 | -9.98 | -8.29 | -7.21 | -28.97 | -25.42 | -66.62 | -68.52 | -132.90 | -173.87 | -234.57 |
| Diluted EPS | -3.20 | -3.20 | -9.71 | -9.98 | -8.29 | -7.21 | -28.97 | -25.42 | -66.62 | -68.52 | -132.90 | -173.87 | -234.57 |
| Weighted Average OS | 8.42M | 5.77M | 2.08M | 1.92M | 1.57M | 1.18M | 757,301 | 311,231 | 242,330 | 238,638 | 206,913 | 207,633 | 205,492 |
| EBITDA | -$31.06M | -$22.52M | -$25.86M | -$24.77M | -$17.52M | -$12.02M | -$19.97M | -$20.14M | -$50.56M | -$54.69M | -$38.87M | -$29.23M | -$35.3M |
| EBITDA Margin | - | -2214.0% | - | -1227.3% | -437.3% | -187.3% | -722.6% | -162.0% | -17373.9% | -8626.2% | -7489.6% | -1886.9% | -3616.3% |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 |
| Assets | |||||||||||||
| Current Assets | |||||||||||||
| Cash and Cash Equivalents | $88.93M | $36.75M | $9.45M | $12.13M | $13.41M | $5.75M | $1.78M | $1.68M | $11.76M | $51.51M | $88M | $1.38M | $1.09M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $69K |
| Cash and Short-Term Investments | $88.93M | $36.75M | $9.45M | $12.13M | $13.41M | $5.75M | $1.78M | $1.68M | $11.76M | $51.51M | $88M | $1.38M | $1.16M |
| Accounts Receivable | $0 | $62K | $102K | $12.42M | $57K | $158K | $5K | $0 | $8M | $0 | $69K | $0 | $215K |
| Inventory | $0 | $0 | $0 | $0 | $100K | $371K | $0 | $0 | $162K | $0 | $0 | $0 | $130K |
| Other Current Assets | $218K | $113K | $65K | $15K | $35K | $0 | $0 | $666K | $442K | $612K | $1.11M | $130K | $999K |
| Total Current Assets | $89.89M | $38.11M | $10.66M | $27.09M | $15.62M | $7.21M | $2.84M | $3.47M | $20.36M | $52.12M | $89.19M | $1.61M | $2.42M |
| Long-Term Assets | |||||||||||||
| Property, Plant & Equipment Net | $0 | $153K | $361K | $556K | $680K | $849K | $1M | $70K | $283K | $444K | $624K | $3.78M | $5.79M |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $5.59M | $9.17M | $6.72M | $2.48M | $2.48M | $2.48M | $0 | $49K | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $6K | $0 | $0 | $0 | $0 | $0 | $2.94M | $2.54M | $4.79M | $1.93M | $1.67M | $7.56M | $7.29M |
| Total Long-Term Assets | $6K | $153K | $361K | $6.14M | $9.85M | $7.57M | $6.43M | $5.09M | $7.55M | $2.38M | $2.35M | $11.34M | $13.08M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $89.9M | $38.27M | $11.02M | $33.24M | $25.47M | $14.79M | $9.27M | $8.56M | $27.92M | $54.49M | $91.53M | $12.95M | $15.5M |
| Liabilities | |||||||||||||
| Current Liabilities | |||||||||||||
| Accounts Payable | $1.13M | $939K | $4.08M | $2.46M | $1.88M | $1.93M | $2.23M | $2.9M | $2.27M | $3.06M | $4.14M | $2.66M | $4.83M |
| Short-Term Debt | $0 | $0 | $191K | $224K | $256K | $84K | $6.17M | $9.38M | $4.27M | $0 | $0 | $155K | $80.91M |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $137K |
| Current Unearned Revenue | $0 | $0 | $17K | $17K | $35K | $31K | $31K | $1.75M | $8.76M | $21K | $219K | $2.8M | $137K |
| Other Current Liabilities | $2.17M | $1.51M | $4.7M | $788K | $3.2M | $1.59M | $1.56M | $0 | $0 | $6.88M | $2.33M | $1.88M | $137K |
| Total Current Liabilities | $6.64M | $5.2M | $10.62M | $7.71M | $8.5M | $6.39M | $13.38M | $18.84M | $26.93M | $11.43M | $7.73M | $6.86M | $87.58M |
| Long-Term Liabilities | |||||||||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $6.33M | $15.32M | $11.06M | $0 | $36.01M | $2.27M |
| Long-Term Unearned Revenue | $18.67M | $18.67M | $18.67M | $18.67M | $0 | $1.01M | $1.03M | $1.07M | $4.5M | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $64.92M | $131.93M | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $152K | $100K | $110K | $684K | $1.26M | $2.92M | $2.86M | $2.7M | $782K | $433K | $245K | $30.79M | $229.39M |
| Total Long-Term Liabilities | $18.82M | $18.77M | $18.95M | $19.69M | $1.75M | $4.61M | $4.72M | $72.58M | $152.03M | $134.01M | $161.78M | $504.89M | $231.65M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $25.46M | $23.96M | $29.57M | $27.4M | $10.25M | $11M | $18.11M | $91.41M | $178.96M | $145.44M | $169.5M | $511.76M | $319.24M |
| Stockholders' Equity | |||||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $91.53M | $438.09M | $229.37M |
| Common Stock | $39K | $32K | $27K | $27K | $901K | $773K | $641K | $435K | $329K | $329K | $329K | $0 | $0 |
| Retained Earnings | -$326.69M | -$299.72M | -$281.04M | -$265.52M | -$248.83M | -$290.04M | -$233.52M | -$233.88M | -$279.06M | -$215.49M | -$195.99M | -$498.81M | -$303.73M |
| Comprehensive Income & Other | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$8.43M | -$9.12M | -$10.45M | -$11.09M | -$11.84M | -$14.28M |
| Other Stockholders' Equity | $391.09M | $311.88M | $256.33M | $254.76M | $238.19M | $209.16M | $183.86M | $150.59M | $127.68M | $124.21M | $117.69M | $0 | $0 |
| Total Equity | $64.44M | $12.2M | -$24.68M | -$10.74M | -$9.74M | -$80.1M | -$49.02M | -$82.85M | -$151.05M | -$90.94M | -$77.97M | -$498.81M | -$303.73M |
| Minority Interest | $0 | $2.1M | $6.13M | $16.58M | $24.96M | $83.89M | $40.18M | $62.48M | $131.44M | $122.52M | $161.53M | $0 | $0 |
| Total Liabilities and Equity | $89.9M | $36.16M | $4.89M | $16.66M | $512K | -$69.11M | -$30.92M | $8.56M | $27.92M | $54.49M | $91.53M | $12.95M | $15.5M |
| Supplementary Data | |||||||||||||
| Total Debt | $0 | $169K | $529K | $716K | $932K | $915K | $7.11M | $15.71M | $19.59M | $11.06M | $0 | $36.17M | $83.17M |
| Net Debt | -$88.93M | -$36.58M | -$8.92M | -$11.41M | -$12.48M | -$4.83M | $5.34M | $14.03M | $7.83M | -$40.45M | -$88M | $34.78M | $82.08M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 |
| Operating Activities | |||||||||||||
| Net Income | -$31.08M | -$22.7M | -$20.25M | -$19.16M | -$17.73M | -$12.8M | -$21.94M | -$23.84M | -$54.65M | -$55.35M | -$41.11M | -$36.1M | -$48.2M |
| Depreciation & Amortization | $16K | $89K | $90K | $92K | $89K | $94K | $39K | $218K | $197K | $265K | $501K | $864K | $1.09M |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | -$3.98M | -$1.11M | $626K | $179K | -$2K | $38K | $0 | $862K |
| Stock-Based Compensation | $3.77M | $2.76M | $1.58M | $0 | $2.36M | $1.01M | $1.52M | $2.68M | $3.65M | $2.64M | $859K | $0 | $2.92M |
| Changes in Working Capital: | |||||||||||||
| Accounts Receivable | $0 | $40K | $71K | -$116K | $101K | -$153K | -$5K | $8M | -$8M | $69K | -$69K | -$733K | $3K |
| Inventory | $0 | $0 | $0 | $0 | -$889K | -$1.98M | $618K | $0 | $194K | -$359K | $547K | $0 | $0 |
| Accounts Payable | $1.53M | $0 | $2.93M | -$856K | $1.83M | -$997K | -$618K | -$6.2M | $2.45M | $4.79M | $2.93M | $0 | $0 |
| Other Working Capital | $362K | -$5.48M | $1.39M | $6.36M | -$1M | $420K | -$2.05M | -$15.54M | $10.39M | -$410K | -$1.37M | -$951K | -$8.82M |
| Total Working Capital Change | $1.89M | -$5.44M | $4.39M | $5.38M | $35K | -$2.71M | -$2.05M | -$7.54M | $5.04M | $4.09M | $2.04M | -$1.68M | -$8.82M |
| Other Non-Cash Items | $142K | -$10K | -$4.89M | -$1.56M | -$4.06M | $380K | $532K | $1.01M | $1.03M | $154K | $722K | $6.14M | $10.47M |
| Net Cash from Operating | -$25.25M | -$25.31M | -$19.08M | -$15.25M | -$19.31M | -$18M | -$23.02M | -$26.86M | -$44.56M | -$48.21M | -$36.95M | -$30.78M | -$41.68M |
| Investing Activities | |||||||||||||
| Capital Expenditures | $0 | $0 | $0 | -$21K | $0 | $0 | -$70K | -$5K | -$57K | -$87K | -$104K | -$33K | -$181K |
| Acquisitions | $0 | $0 | $4.4M | $0 | $0 | $0 | $312K | $12K | $32K | $4K | $25K | -$140K | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $4.4M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | -$4.4M | $0 | $0 | $0 | $0 | $12K | $32K | $4K | $25K | $334K | $25K |
| Net Cash from Investing | $0 | $0 | $4.4M | -$21K | $0 | $0 | $242K | $7K | -$25K | -$83K | -$79K | $161K | -$156K |
| Financing Activities | |||||||||||||
| Debt Repaid | $392K | - | $33K | $808K | -$172K | $4.96M | $10.07M | $4.89M | -$7.5M | -$12.47M | -$19.29M | -$33.56M | -$39.03M |
| Common Stock Issuance | $77.48M | $52.8M | $12.03M | $14.79M | $26.76M | $24.43M | $32.94M | $21.5M | $0 | $0 | $105.77M | $0 | $11K |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $302K | $923K | $0 | -$2.5M | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $341K | $0 | $0 | $0 | $47K | $0 | $0 | $0 | $0 | -$673K | -$89K | $0 | $0 |
| Net Cash from Financing | $77.44M | $52.61M | $12M | $13.98M | $26.98M | $19.47M | $22.87M | $16.61M | $7.5M | $11.79M | $123.64M | $30.91M | $40.8M |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $52.19M | $27.3M | -$2.68M | -$1.29M | $7.67M | $1.47M | $94K | -$10.24M | -$37.09M | -$36.5M | $86.62M | $295K | -$1.03M |
| Supplementary Data | |||||||||||||
| Operating Cash Flow | -$25.25M | -$25.31M | -$19.08M | -$15.25M | -$19.31M | -$18M | -$23.02M | -$26.86M | -$44.56M | -$48.21M | -$36.95M | -$30.78M | -$41.68M |
| Capital Expenditure | $0 | $0 | $0 | -$21K | $0 | $0 | -$70K | -$5K | -$57K | -$87K | -$104K | -$33K | -$181K |
| Free Cash Flow | -$25.25M | -$25.31M | -$19.08M | -$15.27M | -$19.31M | -$18M | -$23.09M | -$26.86M | -$44.62M | -$48.3M | -$37.05M | -$30.81M | -$41.87M |
| Cash at Beginning | $36.75M | $9.45M | $12.13M | $13.41M | $5.75M | $4.28M | $4.18M | $14.42M | $51.51M | $88M | $1.38M | $1.09M | $2.12M |
| Cash at End | $88.93M | $36.75M | $9.45M | $12.13M | $13.41M | $5.75M | $4.28M | $4.18M | $14.42M | $51.51M | $88M | $1.38M | $1.09M |